Emergency FDA Approval For Gilead’s COVID-19 Drug : Remdesivir

FDA Authorizes Emergency Use of Remdesivir The use of Gilead's
Remdesivir broadens in more hospitals around the United States as on
Friday, the FDA granted emergency use authorization for Gilead Science
Inc's (GILD.O) antiviral drug remdesivir for Covid-19. Daniel O'Day,
Gilead Chief Executive said that to help the Covid-19 patients, the
company was donating 1.5 […]

The post Emergency FDA Approval For Gilead's COVID-19 Drug :
Remdesivir appeared first on BioTecNika .

https://www.biotecnika.org/2020/05/fda-authorizes-emergency-use-of-remdesivir-gileads-covid-19-drug/

Biotech News